Several cancers present dysregulated splicing and overexpression of the antiapoptotic isoform Bcl-xL, including solid and hematological malignancies (Dou et al., 2021; Ma et al., 2010; Morales-Martínez and Vega, 2022). Here, BCL2L1 is linked to cancer.